High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial

OBJECTIVE: In the COVID-19 pandemic, the SARS-CoV-2 virus has infected millions of people worldwide. Mortality primarily results from the inflammation state and its complications. High-dose melatonin has been established as an anti-inflammatory agent. This study evaluated high-dose melatonin as an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizadeh, Nafiseh, Dianatkhah, Mehrnoush, Alimohamadi, Yousef, Moradi, Hazhir, Akbarpour, Samaneh, Akrami, Majid, Mansouri, Fariba, Faraji, Neda, Rezaie, Zahra, Alizadeh, Mahboubeh, Hosamirudsari, Hadiseh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098937/
https://www.ncbi.nlm.nih.gov/pubmed/35581997
http://dx.doi.org/10.1016/j.jtumed.2022.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098937/
https://www.ncbi.nlm.nih.gov/pubmed/35581997
http://dx.doi.org/10.1016/j.jtumed.2022.04.012

Ejemplares similares